What is Bolt?
Founded in 2019 and headquartered in Concord, Massachusetts, Bolt operates at the intersection of advanced engineering and clinical practice. The company is dedicated to enhancing surgical outcomes by deploying sophisticated tools designed to optimize efficiency for surgeons globally. By addressing the critical need for precision and streamlined workflows in the operating room, Bolt has positioned itself as a transformative force in the healthtech sector. Its mission-driven approach focuses on democratizing access to high-performance surgical support, ensuring that practitioners can deliver superior patient care regardless of their geographic location or facility constraints.
How much funding has Bolt raised?
Bolt has raised a total of $4.8M across 2 funding rounds:
Angel/Seed
$590K
Stock/Share Issuance
$4.2M
Angel/Seed (2020): $590K, investors not publicly disclosed
Stock/Share Issuance (2026): $4.2M, investors not publicly disclosed
Key Investors in Bolt
Undisclosed Investors
Undisclosed Investors
Undisclosed Investors
What's next for Bolt?
Following this major strategic investment, Bolt is well-positioned to accelerate its product development roadmap and expand its operational footprint. The infusion of capital will likely be directed toward scaling its enterprise-level infrastructure and deepening its integration within global hospital networks. As the company transitions into this next phase of growth, the focus will shift toward long-term sustainability and the widespread adoption of its surgical efficiency solutions. Stakeholders will be monitoring the firm's ability to maintain its technological edge while navigating the complex regulatory and procurement environments inherent to the medical device industry.
See full Bolt company page
